UB Paderborn / Katalog / Suche / in CDI

Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications

Endocrine reviews, 2012-12, Vol.33 (6), p.981-1030

2012

Link zum Volltext

Verfügbarkeit prüfen

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

Fertility and sterility, 2009-02, Vol.91 (2), p.456-488

2009

Link zum Volltext

Verfügbarkeit prüfen

Polycystic ovary syndrome and environmental toxins

Fertility and sterility, 2016-09, Vol.106 (4), p.948-958

2016

Link zum Volltext

Verfügbarkeit prüfen

Lysyl oxidase interacts with AGE signalling to modulate collagen synthesis in polycystic ovarian tissue

Journal of cellular and molecular medicine, 2010-10, Vol.14 (10), p.2460-2469

2010

Link zum Volltext

Verfügbarkeit prüfen

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

European journal of endocrinology, 2014-10, Vol.171 (4), p.P1

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome

Clinical endocrinology (Oxford), 2007-01, Vol.66 (1), p.103-109

2007

Link zum Volltext

Verfügbarkeit prüfen

Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS

Clinical endocrinology (Oxford), 2007-11, Vol.67 (5), p.735-742

2007

Link zum Volltext

Verfügbarkeit prüfen

Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement

Endocrine reviews, 2009-06, Vol.30 (4), p.293-342

2009

Link zum Volltext

Verfügbarkeit prüfen

Oxidative Stress in Polycystic Ovary Syndrome

Current pharmaceutical design, 2016-01, Vol.22 (18), p.2709

2016

Link zum Volltext

Verfügbarkeit prüfen

Crosstalk between Advanced Glycation and Endoplasmic Reticulum Stress: Emerging Therapeutic Targeting for Metabolic Diseases

The journal of clinical endocrinology and metabolism, 2012-07, Vol.97 (7), p.2231-2242

2012

Link zum Volltext

Verfügbarkeit prüfen

Molecular mechanisms of insulin resistance in polycystic ovary syndrome

Trends in molecular medicine, 2006-07, Vol.12 (7), p.324-332

2006

Link zum Volltext

Verfügbarkeit prüfen

Phenotypes and enviromental factors: their influence in PCOS

Current pharmaceutical design, 2012, Vol.18 (3), p.270

2012

Link zum Volltext

Verfügbarkeit prüfen

Metformin in polycystic ovary syndrome

Annals of the New York Academy of Sciences, 2010-09, Vol.1205 (1), p.192-198

2010

Link zum Volltext

Verfügbarkeit prüfen

Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome

European journal of endocrinology, 2010-02, Vol.162 (2), p.193

2010

Link zum Volltext

Verfügbarkeit prüfen

Advanced glycation end-products and insulin signaling in granulosa cells

Experimental biology and medicine (Maywood, N.J.), 2016-07, Vol.241 (13), p.1438-1445

2016

Link zum Volltext

Verfügbarkeit prüfen

Is cardiovascular risk in women with PCOS a real risk? Current insights

Minerva endocrinologica, 2017-12, Vol.42 (4), p.340

2017

Link zum Volltext

Verfügbarkeit prüfen

Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?

Current pharmaceutical design, 2016-01, Vol.22 (36), p.5558

2016

Link zum Volltext

Verfügbarkeit prüfen

Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)

Clinical endocrinology (Oxford), 2008-10, Vol.69 (4), p.634-641

2008

Link zum Volltext

Verfügbarkeit prüfen

Structural, biochemical and non-traditional cardiovascular risk markers in PCOS

Current pharmaceutical design, 2013-10, Vol.19 (32), p.5764

2013

Link zum Volltext

Verfügbarkeit prüfen

Strong and positive association of Endothelin-1 with AGEs in PCOS: A causal relationship or a bystander?

Hormones (Athens, Greece), 2011-10, Vol.10 (4), p.292-297

2011

Link zum Volltext

Verfügbarkeit prüfen

Indices of Low-Grade Inflammation in Polycystic Ovary Syndrome

Annals of the New York Academy of Sciences, 2006-12, Vol.1092 (1), p.175-186

2006

Link zum Volltext

Verfügbarkeit prüfen

Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome

Journal of bone and mineral metabolism, 2011-03, Vol.29 (2), p.201-206

2011

Link zum Volltext

Verfügbarkeit prüfen

PCOS Forum: research in polycystic ovary syndrome today and tomorrow

Clinical endocrinology (Oxford), 2011-04, Vol.74 (4), p.424-433

2011

Link zum Volltext

Verfügbarkeit prüfen

PCOS in adolescents

Best practice & research. Clinical obstetrics & gynaecology, 2010-04, Vol.24 (2), p.173-183

Diamanti-Kandarakis, Evanthia, MD, PhD

2010

Link zum Volltext

Verfügbarkeit prüfen

Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome

Clinical endocrinology (Oxford), 2014-09, Vol.81 (3), p.426-431

2014

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

Polycystic ovary syndrome and environmental toxins

Lysyl oxidase interacts with AGE signalling to modulate collagen synthesis in polycystic ovarian tissue

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome

Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS

Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement

Oxidative Stress in Polycystic Ovary Syndrome

Crosstalk between Advanced Glycation and Endoplasmic Reticulum Stress: Emerging Therapeutic Targeting for Metabolic Diseases

Molecular mechanisms of insulin resistance in polycystic ovary syndrome

Phenotypes and enviromental factors: their influence in PCOS

Metformin in polycystic ovary syndrome

Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome

Advanced glycation end-products and insulin signaling in granulosa cells

Is cardiovascular risk in women with PCOS a real risk? Current insights

Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?

Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)

Structural, biochemical and non-traditional cardiovascular risk markers in PCOS

Strong and positive association of Endothelin-1 with AGEs in PCOS: A causal relationship or a bystander?

Indices of Low-Grade Inflammation in Polycystic Ovary Syndrome

Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome

PCOS Forum: research in polycystic ovary syndrome today and tomorrow

PCOS in adolescents

Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome

Aktive Filter

Suchergebnisse filtern